Salima Qamruddin MD (@SalimaqMD) header
Salima Qamruddin MD (@SalimaqMD) profile picture

Passionate about Women’s Heart Health and Echocardiography @OchsnerCardio, Review editor @FrontCVMedicine @ASE360 @KeckMedUSC @ClevelandClinic alum

New Orleans, LA
Joined February 2020
Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)Photo by Salima Qamruddin MD (@SalimaqMD)
Honored to receive Dr.Edward Frohlich mentorship award ⁦@OchsnerCardio⁩ ⁦@Stent4U⁩ @OchsnerHealth⁩ ⁦@GEHealthCare⁩ ⁦@Skhatib55⁩ ⁦@MCash94⁩ ⁦@ASE360⁩ ⁦@WomenAs1⁩ ⁦@GoRedForWomen⁩ ⁦@DrMarthaGulati⁩ ⁦@pattypellikka⁩
9
2
28
2,625
Salima Qamruddin MD retweeted
🚨 #TCT2026 | EVOQUE TTVR 🫀 Dr. Raj Makkar: STS/ACC TVT Registry (N=3,018) 🔹 98.5% implant success 🔹 3.3% 30-day mortality 🔹 95% ≤mild TR at 1 year* 🔹 KCCQ ↑27.8 points* 🔹 Similar TR reduction with/without CIED *Available 1-year follow-up #StructuralHeart @crfheart @TCTMD @ladyheart_md @Shikha_Cardio #CardioX #CardioTwitter
8
25
1,844
Salima Qamruddin MD retweeted
🚨 #TCT2026 | How durable is M-TEER? 🫀 @jtsaxon presents 4-year real-world data (N=2,325). 🔹 Severe MR recurrence: 24.3% 🔹 Reintervention: 5.6% 🔹 Residual mild-moderate vs mild MR → recurrence HR 2.90 🔹 Recurrent severe MR → mortality HR 2.57 🔹 Post-TEER gradient ≥5 mmHg was not significantly associated with recurrence. 🎯 Procedural success is only the beginning. Durable MR reduction matters! #StructuralHeart @crfheart @TCTMD @ladyheart_md @Shikha_Cardio #CardioX #CardioTwitter
5
14
1,140
Salima Qamruddin MD retweeted
In people with a new diagnosis of coronary artery disease, no prior statin Rx (N=104), getting the LDL down to ~40 vs 70 mg/dL (via the 2 regimens, randomized, shown below) led to 20% more regression of atherosclerotic plaque in just 18 months @JAMACardio The lower the LDL, the more regression jamanetwork.com/journals/jam…
46
125
11
706
157,322
Salima Qamruddin MD retweeted
Lots of debate this week on whether journals should ban AI in peer review. We actually tested this in our new preprint, and the results were pretty clear to me. For context, I've reviewed for most of the big journals and evaluated 1,000 human reviews as an editor. I love to read and evaluate science. TLDR: From now on I won't do any peer review without AI. For clinical trials, I'd even call human-only review dangerous 🧵
138
522
179
2,145
291,174
Salima Qamruddin MD retweeted
🫀 Can coronary atherosclerosis actually regress? Our new randomized FLOWPROMOTE trial analysis, published TODAY in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering! Atherosclerosis is not necessarily a one-way process. 📄 JAMA Cardiology: doi.org/10.1001/jamacardio.2… #Atherosclerosis #LDL #Cardiology #CCTA
80
382
59
1,394
265,007
"The truth is behind the paywall. Lies are free." Privileged to hear former FDA Commissioner Dr.Robert Califf at @OchsnerCVFellow Grand Rounds today. His charge: better evidence, less misinformation, and AI that lifts everyone. #CardioTwitter #AIinHealthcare @OchsnerHealth @ACCinTouch @AHAScience
4
12
1,508
Salima Qamruddin MD retweeted
Have you been using flow rate during your low flow low gradient AS DSE for further determination of #AS severity? Excellent #EchoFirst paper in @CircImaging on this During DSE, relying on AVA + mean gradient ≥40 mmHg can leave many studies indeterminate. Using transvalvular flow rate ≥210 mL/s + AVA <1.0 cm², or projected AVA, substantially improves classification and risk stratification. #AorticStenosis #CardioX #EchoFirst ahajournals.org/doi/10.1161/…
4
18
1
67
4,900
Salima Qamruddin MD retweeted
Dear cardiology fellows 🫀 I built a free TTE cheatsheet with @claudeai I keep open while reading echos: guideline cutoffs, 17-segment walls by view, valve grading and 15 built-in calculators (AVA, SV/CO). Check it out 👇 echoguide.netlify.app #EchoFirst #CardioTwitter
24
133
5
635
64,139
EF 60% doesn't mean the heart is fine 🫀 Thank you @CASivaram1 &@OUCardsFellows for hosting me at Cardiology Grand Rounds on strain echo: basics, applications & pitfalls. Key pearls 🧵👇 2/ Longitudinal fibers sit in the vulnerable subendocardium and fail first. GLS picks up dysfunction while EF still looks normal. GLS less negative than −16% = likely significant dysfunction, across vendors. 3/ Where strain changes management: • Cardio-onc: >15% relative GLS drop • Amyloid: apical sparing • HCM: read the bull's-eye pattern • Asymptomatic severe AS: GLS worse than −14.7% → 2.5x mortality • CAD: reduced basal/mid GLS at rest 4/ Pitfalls: foreshortening, ROI width, valve timing, afterload, AF. Myocardial work adds BP to the picture. AI cuts observer variability, but it can't fix a bad image. Human oversight still matters. @OchsnerHealth @OchsnerCVFellow #EchoFirst #CardioTwitter #StrainEcho @iamritu @ASE360 @GEHealthCare @CGMihosDO @JamesDThomasMD1 @RigolinVera @pattypellikka
6
38
1,799
Salima Qamruddin MD retweeted
We Must Pace the Frontier: I’ve written a new essay on why the AI industry should slow down, with a three-part plan for doing so. Anthropic is unilaterally committing to the first of these steps. We’ll provide third-party evaluators with permanent, employee-level access to our systems, so that they can verify adherence to our safety measures, report on incidents, and assess models’ alignment during training. You can read the full post here: darioamodei.com/post/we-must…
10,537
16,294
11,366
87,526
77,185,225
This is such a STRIKING 3D echo (but, I hope to never see this in my own lab)... #JADEL @ASE360 @CASEfromASE
We report the case of a young man with prior mitral & tricuspid ring annuloplasty who presented with sudden dyspnea & was ultimately diagnosed with mitral annuloplasty ring dehiscence associated with a pericardial hematoma. Read our @CASEfromASE report: bit.ly/4xRxXWV
1
5
1
25
3,813
Salima Qamruddin MD retweeted
Quadricuspid aortic valve — because three cusps are simply too ordinary. When you’re the unicorn (of aortic valves), you don’t need to beg for attention. You just shine and let them realize your rarity . 🦄 💜 🫀🎇 -> rare congenital anomaly with four cusps instead of three, found in roughly 0.01–0.04% of the population -> Most commonly associated with aortic regurgitation #Echofirst #yesCCT #CVimaging
2
26
1
94
5,022
Thank you @ericpetersonMD for cardiology grand rounds @OchsnerID Great grand rounds talk on AI in clinical research/trials — LLMs extracting data from EHRs could replace manual extraction, but algorithmic bias and model accuracy still need rigorous evaluation. Foundational models are expected to keep improving with iteration. Thank you! @ACCinTouch @American_Heart @OchsnerCVFellow
5
259
Salima Qamruddin MD retweeted
#echofirst ✅ Large iatrogenic ASD during structural intervention ✅ Comments on pattern of shunting & hemodynamics inference based on shunting? @argulian @iamritu @purviparwani @NMerke @echo_batman @alex1708ander @alexsfelixecho @Hragy @DocStrom @denisamuraru @johnsoncardiol @DrRajeshG1 @BryanTanMD
8
19
53
3,209
Salima Qamruddin MD retweeted
More exercise = more cardiac abnormalities? Masters athletes have fewer risk factors but more findings, such as #AFib and coronary calcification, compared to sedentary peers. Guidelines haven’t addressed them until now! jacc.org/doi/10.1016/j.jacc.… #JACC #SportsCardio #CVD
4
58
3
151
14,824
Multiple papillary fibroelastomas of the aortic valve. On resection multiple PFEs are seen in 21% of cases (Mayo study) @ASE360 @iamritu @lucysafi @pattypellikka #echofirst #cardiotwitter @OchsnerHealth @OchsnerCVFellow
1
1
9
438
Many people thought this was LV noncompaction - making this a good (incorrect) distractor. Without more info, it meets conventional criteria. However, LVNC should be considered a diagnosis of exclusion. More info confirms an alternative diagnosis.
#JADEL New in CASE @CASEfromASE: sciencedirect.com/journal/ca… Emphasizing the value of MMI in assessment of heart failure, check out the latest finding in this low LVEF: A. ILVNC (noncompaction) B. HCM (hypertrophic) C. DCM (dilated) D. VHD (valves) E. Other (cors) @ASE360
6
37
6,028